The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Biomarkers of response to immunotherapy in pancreatic ductal adenocarcinoma (PDAC) with homologous recombination deficiency (HRD).
 
Clara Oh
No Relationships to Disclose
 
Kieran Sweeney
Employment - Caris Life Sciences
Stock and Other Ownership Interests - Caris Life Sciences
Travel, Accommodations, Expenses - Caris Life Sciences
 
Andrew Elliott
Employment - Caris Life Sciences
 
George Sledge
Employment - Caris Life Sciences
Leadership - Caris Life Sciences; Syndax
Stock and Other Ownership Interests - Caris Life Sciences
Travel, Accommodations, Expenses - Caris Life Sciences
 
Vaia Florou
Consulting or Advisory Role - AADi; Agenus; Deciphera; Ipsen; Merus; SpringWorks Therapeutics; SpringWorks Therapeutics
 
Moh'd Khushman
Stock and Other Ownership Interests - Cardiff Oncology
Consulting or Advisory Role - Abbvie; bristol-myers squibb; Cardinal Health; Elevar Therapeutics; Exelixis; Muerus; TriSalus Life Sciences
Speakers' Bureau - Caris Life Sciences
Research Funding - Abbvie (Inst); FOGPharma (Inst); IgM Biosciences (Inst); Torl Biotherapeutics (Inst)
 
Emil Lou
Stock and Other Ownership Interests - Ryght
Honoraria - Boston Scientific; Colorectal Cancer Alliance; Daiichi Sankyo/UCB Japan (Inst); GlaxoSmithKline; Novocure
Consulting or Advisory Role - Boston Scientific; Novocure; Novocure; Novocure; Novocure
Research Funding - Intima; Novocure
Travel, Accommodations, Expenses - GlaxoSmithKline
(OPTIONAL) Uncompensated Relationships - Caris Life Sciences; Minnetronix Medical; NomoCan
 
Rachna Shroff
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Genentech; Jazz Pharmaceuticals; Merck; Merus
Research Funding - Actuate Therapeutics; Bristol-Myers Squibb; Compass Therapeutics; Exelixis; Faeth Therapeutics; Fujifilm; Immunovaccine; Lisata; Loxo/Lilly; Merck; NGM Biopharmaceuticals; Novocure; Nucana; Rafael Pharmaceuticals; Seagen
 
Marcus Noel
Consulting or Advisory Role - Celgene; Ipsen; Merus; Moderna Therapeutics; Taiho Pharmaceutical
Speakers' Bureau - Celgene; Daiichi Sankyo/Astra Zeneca; Taiho Pharmaceutical
Research Funding - ERYTECH Pharma
 
Brandon Huffman
Consulting or Advisory Role - Loxo/Lilly
 
Harshabad Singh
Honoraria - UpToDate
Consulting or Advisory Role - Dewpoint Therapeutics; Merck
Speakers' Bureau - Peerdirect
Research Funding - AstraZeneca/Daiichi Sankyo
Travel, Accommodations, Expenses - Dava Oncology
 
Erkut Borazanci
Consulting or Advisory Role - Arcus Biosciences; BPGbio; ClearNote Health; Corcept Therapeutics; Merus; NanOlogy; VCN Biosciences
Research Funding - BioNTech (Inst); Biosplice (Inst); Bristol-Myers Squibb (Inst); Corcept Therapeutics (Inst); Daiichi Sankyo (Inst); Helix BioPharma (Inst); Idera (Inst); Lilly (Inst); Merck (Inst); Minneamrita Therapeutics (Inst); Pharmacyclics (Inst)
 
Gretel Terrero
No Relationships to Disclose
 
Nipun Merchant
No Relationships to Disclose
 
Piyush Kumar Sharma
No Relationships to Disclose
 
Anna Bianchi
Stock and Other Ownership Interests - Revolution Medicines
 
Ramiro Verdun
No Relationships to Disclose
 
Luis Nivelo
No Relationships to Disclose
 
Jashodeep Datta
Research Funding - Cantargia AB
 
Peter Hosein
Consulting or Advisory Role - FibroGen; Revolution Medicines